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Diabetes is one of the most common and costly chronic diseases, affecting more than 30 million 
Americans, with a total annual cost of $245 billion.1 
 
Prevalence continues to increase as obesity rises, with the highest rates of diabetes found in 
minorities and older Americans. Consequences of diabetes include hypertension, coronary heart 
disease, stroke, chronic kidney disease, and blindness.2 Despite significant medical advancement 
in treatment, diabetes remains the seventh leading cause of death in the United States.3 As a 
result, health care providers must consider the impact of financial and educational barriers in 
outcomes associated with diabetic management. 
 
Diabetes is associated with a significant financial burden both to the patient and to the health 
care system. In 2012, the estimated cost of direct med- ical care in diabetes was $176 billion.1 
The cost of prescription medications accounted for 18% of that cost, while diabetic supplies 
accounted for 12%.1 
 
Individuals with diabetes had more than double the cost of annual medical expenditures 
compared with those without, with an average annual cost of $13,700.1 Although government 
and private insurance provide patient assistance in managing these costs, financial barriers may 
still pose a significant obstacle to patients in optimizing diabetic management. Patients who are 
unable to afford their medications and diabetic supplies will have less than optimal control of 
their blood sugar and glycated hemoglobin, putting them at increased risk for diabetic 
complications. 
 
Current guidelines provide detailed stepwise recommendations for initiation and adjustment of 
oral and injectable glycemic agents. A wide variety of agents are available for management of 
diabetes. However, agent utilization and medication compliance may depend on a variety of 
factors, including cost. Diabetic oral and injectable agents and diabetic supplies such as glucose 
meters, test strips, syringes, and lancets, can have a high cost, which limits patient adherence to 
therapeutic regimens. Newer agents may be of relatively lower utility based on high cost and 
moderate glycemic effect.4 The high cost of insulin, which not only is the mainstay therapy for 
type 1 diabetes but also is required by many patients with type 2 diabetes, further complicates the 
management of the disease for for individuals with financial barriers. 
 
This is of concern to health care providers because inadequate management of diabetes results in 
short- and long-term complications. Patients with diabetes and no health insurance have fewer 
physician visits and are prescribed fewer medications for management of their diabetes. Patients 
with diabetes make up 11.9% of all emergency department visits in the United States.1 Hispanic 
and non-Hispanic blacks are at greater risk for developing diabetes and serious associated health 
complications, including chronic kidney disease.3,5 This may be attributed to a combination of 
genetics, diet, and exercise. However, access to health care resources may also play an important 
role.6 
 
For those who qualify, a variety of government and nongovernment programs (table 17-10) can 
help with covering health care expenses.7 The role of the pharmacist in educating patients about 
their disease state and therapies to promote compliance, as well as providing valuable resources 




Managing the Cost of Diabetes  
Medicare 
Medicare, a federal health insurance program for patients 65 years and older, can assist with 
covering the cost of diabetic services, supplies, and equipment. However, patients may be 
required to meet a deductible or have a co-payment to supplement insurance coverage.7 Medicare 
Part B provides coverage for health care provider ser- vices and medical equipment, paying for 
80% of covered services once a deductible has been met.7 Medicare Part D provides coverage for 
diabetic medications, including insulin, as well as diabetic supplies such as needles and 
syringes.7 Patients should be advised that Part D requires separate enrollment and coverage will 
vary based on whether the plan selected is a health maintenance organization, a preferred 
provider organization, or a private fee-for-service plan.7 Cost should be considered when 
choosing a therapeutic agent, as Medicare insurance is not a guarantee of full coverage. 
Medications may still require a prior authorization for approval or have a high co-payment 
despite approval.11,12 Additionally, most Medicare plans have a coverage gap, known as the 
donut hole, in which patients are responsible for higher out-of-pocket expenses once they hit a 
certain limit for their plan.8,13 Affording diabetic medications and supplies during this coverage 




Medicaid is a state-run health insurance program for patients with low income. The Children’s 
Health Insurance Program provides free or low- cost coverage for children whose parents do not 
qualify for Medicaid but still require assistance with insurance coverage.7 The specific require- 
ments for enrollment and the services covered, including drug formularies and diabetic supply 
coverage, may vary from state to state. Patients can enroll at city or county department of social 
service offices.7 To receive federal funding, all states must provide services, including inpatient 
and outpatient care, physician visits, and long- term care. Although prescription drug coverage 
is  optional, all states have chosen to include it.9 State insurances may be subject to limited 
formularies and variable prior-authorization processes.9 Health care providers should refer to 
insurance-specific formularies and prescribe cheaper alternatives for nonformulary agents. 
 
Private Health Insurance 
Private health insurance may be provided through an employer or through individual purchase. 
Under the Affordable Care Act, patients can no longer be denied coverage for preexisting 
conditions.7 However, coverage does not guarantee that patients are able to afford their diabetes 
treatment and care, as they may be subject to high deductibles, co-payments, and limited 
formularies based on their specific insurance plan.12 If coverage is provided through an 
employer, patients will lose coverage if they leave their employer unless they elect to pay for the 
insur- ance on their own through the Consolidated Omnibus Budget Reconciliation Act.7 
 
Supplemental Financial Assistance Programs 
Regardless of whether patients qualify as low income, they may require additional assistance 
with medication coverage to supplement their insurance. To minimize costs, patients can be 
switched from expensive agents to cheaper alternatives. Many community pharmacies offer a 
low-cost generic list or program, which can be provided to the patient and the health care provid- 
er as a reference to guide agent selection. Additionally, diabetic supplies including meters, 
syringes, and test strips are available as store-brand generics, which can lower cost.10 
 
Manufacturer assistance programs can also supplement the costs of medication and diabetic 
supplies for eligible patients. These programs are typically available for brand-name agents, and 
the details of eligibility and assistance will vary based on the manufacturer and the specific 
program. Drug manufacturers may provide co-payment assistance cards for patients with private 
or commercial insurance with a high co-payment.7 This can signifi- cantly lower the cost of 
eligible brand-name prescriptions but is limited to patients with nongovernment insurance.14 
Programs targeting low-income individuals will provide assistance with cost once eligibility is 
determined.15 Eligibility may need to be reevaluated on a recurring basis. 
Additional supplemental programs listed in table 27,16 can help patients identify drug assistance 
programs and determine eligibility based on their medication needs. 
 
 
The Pharmacist's Role  
The cost of diabetic treatment and supplies can affect compliance, placing patients at an 
increased risk for complications of diabetes. The pharmacist can provide valuable education on 
the patient’s disease state by emphasizing the importance of medi- cation compliance and 
nonpharmacologic interventions such as diet and exercise. Pharmacist-conducted patient 
education and counseling can help prevent the risk of long-term complications, including 
diabetic nephropathy, chronic kidney disease, and coronary artery disease in patients with 
diabetes.17 Beyond that, the pharmacist can help patients with identifying financial resources to 
assist with payment through insurance enrollment and supplemental assistance programs. 
Additionally, the phar- macist can provide recommendations for cheaper alternatives to therapies 




To improve patient adherence, optimize management of diabetes, and prevent long-term 
complications, financial barriers must be anticipated and addressed. There are a variety of 
resources available to supplement costs associated with diabetes treatment and supplies, 
including government and nongovern- ment insurance and patient assistance programs. The 
pharmacist can play a valuable role in optimizing diabetes management by educating the patient 
on the importance of medication compliance and providing information on available resources to 
address financial concerns. 
 
LARESSA BETHISHOU, PHARMD, BCPS, is an assistant professor of pharmacy practice at 
Chapman University School of Pharmacy and faculty in residence at Hoag Memorial Hospital 
Presbyterian, Newport Beach, California. 
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